
Company valuation, historical trends, and peer comparisons.
According to Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 88.43B. This represents a change of -2.40% compared to the average of 90.60B of the last 4 quarters.
The mean historical Enterprise Value of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. over the last ten years is 30.01B. The current 88.43B Enterprise Value has changed 194.68% with respect to the historical average. Over the past ten years (40 quarters), 6990.HK's Enterprise Value was at its highest in in the September 2025 quarter at 106.16B. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.
Average
30.01B
Median
15.71B
Minimum
7.54B
Maximum
78.22B
Discovering the peaks and valleys of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 131.72%
Maximum Annual Enterprise Value = 78.22B
Minimum Annual Increase = 0%
Minimum Annual Enterprise Value = 7.54B
| Year | Enterprise Value | Change |
|---|---|---|
| 2025 | 78.22B | 131.72% |
| 2024 | 33.76B | 114.84% |
| 2023 | 15.71B | 6.02% |
| 2022 | 14.82B | 96.61% |
The current Enterprise Value of Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
42.56B
5-year avg
30.01B
10-year avg
30.01B
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.’s Enterprise Value is less than Innovent Biologics, Inc. (106.09B), greater than Zai Lab Limited (2.21B), greater than HUTCHMED (China) Limited (2.46B), greater than InnoCare Pharma Limited (10.85B), greater than CStone Pharmaceuticals (5.34B), greater than Akeso, Inc. (62.09B), greater than Antengene Corporation Limited (1.08B), greater than TYK Medicines, Inc (975.77M), less than GenFleet Therapeutics (Shanghai) Inc. (0), greater than ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (783.90M),
| Company | Enterprise Value | Market cap |
|---|---|---|
| 106.09B | $142.30B | |
| 2.21B | $20.12B | |
| 2.46B | $19.42B | |
| 10.85B | $17.55B | |
| 5.34B | $7.49B | |
| 62.09B | $77.28B | |
| 1.08B | $1.86B | |
| 975.77M | $1.21B | |
| 0 | $10.37B | |
| 783.90M | $1.26B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Enterprise Value?
How can you use the Enterprise Value?
What is Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.'s Enterprise Value?
What is the highest Enterprise Value for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK)?
What is the 3-year average Enterprise Value for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK)?
What is the 5-year average Enterprise Value for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK)?
How does the current Enterprise Value for Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) compare to its historical average?